Meet the 29-year-old who founded a company that's using technology to find treatments for diseases thought to be incurable

Verge Genomics

• Alice Zhang started Verge Genomics in 2015 with Jason Chen to combine innovation in neuroscience, machine learning and genomics and apply it to the drug discovery process. 
• The vision for Verge was to become the first pharmaceutical company that automated its drug discovery engine, helping to rapidly develop multiple lifesaving treatments in diseases like Alzheimer's disease, ALS, and Parkinson's disease where no cure exists today. 
• On Monday, the San Francisco-based company announced it had raised $32 million in series A funding, led by DFJ, bringing its total amount raised to $36.5 million.

---

The drug development process is laden with problems that make it lengthy and expensive. Right now, it takes 12 years and $2.6 billion to get a single drug to market, with the drug discovery and development process costing $1.4 billion. 

Verge Genomics, run by 29-year-old Alice Zhang, is trying to address these problems by making drug discovery faster and cheaper. See the rest of the story at Business Insider

NOW WATCH: How NASA saved the world

See Also:

• This healthcare startup is using technology to save millions of babies
• Doctors are calling out a new drug that helps people with addiction for costing more than $1,700 a week — while a generic costs just $1
• Researchers may have found new a way to help treat type 1 diabetes – and it's with a drug that has been on the market for over 30 years

SEE ALSO: This healthcare startup is using technology to save millions of babies